Back

Co-administration of low concentrations of matrix metalloproteinase 2, myosin light chain kinase and nitric oxide synthase inhibitors protects heart from ischemia/reperfusion injury

26 August 2017 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 6 - Latest on STEMI Infarction acute phase STEMI ESC Premium Access ESC Congress 2017

About the speaker

Photo
Professor Iwona Bil-Lula

Wroclaw Medical University, Wroclaw (Poland)

70 More presentations in this session

Presentation thumbnail
Acquired thrombocytopenia after transcatheter aortic valve implantation (TAVI): association with clinical outcome
Doctor C. Guerreiro (Vila Nova de Gaia, PT)
Abstract
Presentation thumbnail
Ventricular conduction blocks: prevalence, temporal evolution, and impact on survival in cardiogenic shock
Doctor H. Tolppanen (Helsinki, FI)
Abstract Slides
Presentation thumbnail
Pre-hospital and in-hospital mortality from myocardial infarction in Berlin
Professor M. Stockburger (Nauen, DE)
Abstract Slides
Presentation thumbnail
Development of antithrombotic therapy and bleeding complications in patients with ACS over time: Data from a local myocardial infarction registry
Doctor J. Roehnisch (Berlin, DE)
Abstract Slides
Presentation thumbnail
8-hydroxy-2-deoxyguanosine predicts microvascular obstruction after primary percutaneous coronary intervention in patients with anterior ST-segment elevation myocardial infarction.
Mr Y. Minamimoto (Yokohama, JP)
Abstract

Access the full session

Session thumbnail
Poster session 6 - Latest on STEMI

The Event

Event poster

ESC Congress 2017

26 August - 30 August 2017

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources